Hepatitis C and Medical Cannabis: What Research Shows
Hepatitis C is cured with direct-acting antivirals (DAAs): pills taken for 8 to 12 weeks[1] – and medical cannabis does not replace them or treat the virus. What people with hepatitis C ask a physician about is different: tiredness, nausea, poor sleep and appetite, and whether cannabis is safe for an already strained liver and for the antiviral treatment.
Smoke and vapor
Smoking and vaping send hot smoke or vapor through the throat and lungs. That is the airway part of the answer, and it does not apply to forms that are swallowed, held under the tongue or put on the skin.
Any form
Whatever reaches the blood is handled by the liver, can interact with antivirals and other medicines, and THC can cause drowsiness. No driving after use, whatever the form.
Shared devices
Hepatitis C spreads through blood. A pipe, joint or vape passed around can carry traces of blood from cracked lips or gums, so a device of your own matters here more than with most conditions.
Built on peer-reviewed research published from 2011 to 2025: cohort studies and trials in people with hepatitis C, plus laboratory and computer modeling work.
Living with hepatitis C: tiredness, nausea and worry about your liver
For many people the diagnosis arrives without a single symptom: a routine blood test, a letter from a blood bank, a check during pregnancy. For others it comes after months of feeling worn down for no clear reason. Either way, what follows tends to look alike: a tiredness that sleep does not fix, mornings when food is the last thing you want, nights spent awake, and a quiet worry every time you feel a twinge under the right ribs.
Then come the questions that make it harder. Will anything I take damage my liver further? Could it get in the way of the antiviral pills? Who will find out? Hepatitis C still carries a stigma because of how it spreads, and many people would rather not explain their diagnosis to a stranger, let alone fill in forms about it. Some have already tried cannabis on their own and are not sure whether to mention it to their hepatologist.
This page sorts that out in order: what is known for certain about the virus and its cure, what research shows about cannabis in people with hepatitis C (and how thin it is), and where the decision belongs with a physician who sees your liver tests.
What bothers you most?
Choose one to see where this page answers it.
Fatigue
The most common complaint in chronic hepatitis C, and it often lingers after cure. No study in people with hepatitis C has tested cannabis for it, and THC can make daytime tiredness worse. What the studies did test.
Nausea and appetite
Nausea comes with the infection for some people and with medicines for others. Cannabinoids are studied for nausea in other conditions, not yet in hepatitis C. See the evidence for hepatitis C.
Sleep
Broken sleep feeds the fatigue. Feeling drowsy after THC is not the same as sleeping better, and it adds to sleeping pills. What is known for hepatitis C.
Worry about the liver
The fair question is what any form does to a liver that is already inflamed, and why alcohol is the bigger risk. Cannabis, alcohol and the liver.
What is hepatitis C, and how do you get it?
Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). “Hepatitis” simply means inflammation of the liver. The virus spreads when blood from an infected person, even an amount too small to see, enters the body of someone who is not infected[1]. It is not spread through air, food or water.
Doctors speak of two phases. The first months after infection are called acute hepatitis C. More than half of people who are infected do not clear the virus and go on to chronic infection[2], which can damage the liver quietly for decades.
Acute: the first six months
What it is: the early stage, right after the virus enters the body.
How often there are symptoms: most people feel nothing at all; some have tiredness, nausea or yellow eyes.
What it means: some people clear the virus on their own; a blood test months later tells whether it stayed.
Chronic: when it stays
What it is: the virus is still in the blood after the first six months.
How often: more than half of people who are infected[2].
What it means: slow liver scarring over years if untreated, and the stage that antiviral pills cure.
Is this a way it spreads?
Choose a situation to see whether it can pass the virus on.
Choose a situation above to see the answer.
Sharing needles or drug equipment: yes. This is the most common way hepatitis C spreads in the United States today: needles, syringes and other injection equipment carry blood from one person to the next[3]. Studies of people who inject drugs show how concentrated the risk is: in a 2018 hospital survey of 300 people in Saudi Arabia, 42.7% had hepatitis C[4], and among Hispanics in California, heroin use was tied to infection with an odds ratio of 6.84[5].
Shared razor or toothbrush: yes, less often. Razors, toothbrushes, nail clippers and glucose monitors can hold traces of blood, and the CDC lists them as a route[3]. Keep these items to yourself, and so should people you live with.
Blood transfusion before 1992: yes, in the past. People who received blood or blood products before July 1992, when screening of donated blood became routine, are a recognized risk group and should be tested[2].
Sex – less often. Sexual transmission is possible but uncommon; the risk is higher with blood contact, several partners or HIV[2][3].
Mother to baby: yes, less often. About 6 of every 100 babies born to a mother with hepatitis C are infected[3], which is why every pregnancy is tested[6].
Shared pipe or vape: possibly. Hepatitis C is not airborne, but a mouthpiece can carry blood from cracked lips or gums. This has not been studied directly; a device of your own takes the question off the table.
Hugging, kissing, sharing food: no. Hepatitis C is not spread by sharing eating utensils, hugging, kissing, holding hands, coughing or sneezing, or through food and water[1].
Quick answers
Is hepatitis C contagious?
Yes, but only through blood. As long as the virus is in the blood, it can be passed on through shared needles, razors or other blood contact[3]. After a cure, the virus is gone and cannot be passed on, although a new infection is possible after a new exposure.
Which organ does hepatitis C affect?
The liver. Over years, the inflammation can scar it, and chronic hepatitis C is a leading cause of liver cancer and the leading cause of liver transplants in the United States[1]. It can also affect the rest of the body, see what hepatitis C does to your body.
What is the ICD-10 code for hepatitis C?
In the ICD-10-CM system used on US medical records, acute hepatitis C is coded under B17.1 (B17.10 without hepatic coma, B17.11 with hepatic coma) and chronic hepatitis C is B18.2[7]. The code on your records is one of the things a physician checks when your state asks for a diagnosis.
Hepatitis C symptoms: how long before they show up?
Often they never do, at least not for years. Most people with a new infection notice nothing. When symptoms of acute hepatitis C appear, they usually start 2 to 12 weeks after the virus entered the body, and the range runs from 2 to 26 weeks[2]. Chronic hepatitis C can stay silent for decades, which is why the CDC asks every adult to be tested at least once[6] rather than waiting for symptoms.
Show one column
Pick what you want to compare across the stages.
| Stage | What you may notice | What happens in the liver | What to do |
|---|---|---|---|
| First 2-12 weeks | Usually nothing. Some people have tiredness, fever, nausea, poor appetite, dark urine, pale stools or yellow eyes and skin[2]. | The virus multiplies and the liver becomes inflamed; liver enzymes on a blood test may rise. | After a possible exposure, ask for a test. An RNA test finds the virus earlier than antibodies do. |
| Years of chronic infection | Often nothing, or tiredness, low mood, aches and trouble concentrating that are easy to blame on something else. | Slow scarring (fibrosis). About 5 to 25 of every 100 people with chronic hepatitis C develop cirrhosis over 10 to 20 years[2]. | Treat it. Antiviral pills cure most people at this stage[1]. |
| Advanced liver disease | Yellow skin, a swollen belly, easy bruising, confusion, vomiting blood or black stools. | Cirrhosis that can lead to liver failure or liver cancer[1]. | Urgent care for the warning signs; regular follow-up with a liver specialist even after cure. |
The warning signs in the last row are not something to manage at home or to treat with cannabis. They need a doctor the same day.
Could medical cannabis be worth discussing for your hepatitis C symptoms?
Fifteen short questions about your tests, treatment, liver and medicines. Your answers stay on this page and show what to raise with a physician.
15 questions · about a minute · your answers stay in this browser
Is hepatitis C curable? Can you treat it?
Yes. In most people, hepatitis C can be cured. Today’s treatment is a course of direct-acting antiviral pills, usually for 8 to 12 weeks, and it cures more than 95% of people, usually without notable side effects[1][8]. “Cured” has a precise meaning here: the virus can no longer be found in the blood 12 weeks after the last pill, which doctors call a sustained virologic response (SVR)[9]. The treatment choices are laid out in the national AASLD-IDSA guidance that hepatologists and primary care doctors follow[9].
The cure works in real life, not only in trials, including for people whose lives are complicated by addiction treatment.
Can it go away on its own?
Sometimes, in the acute phase: some people clear the virus without treatment in the first months. Fewer than half do; more than half go on to chronic infection[2]. Only an RNA test tells which group you are in.
Chronic needs treatment
Once the infection is chronic, it rarely clears by itself. Antiviral pills are the treatment, and early treatment spares the liver years of scarring. Antibodies stay in the blood after cure, so the follow-up is an RNA test[6].
Who treats hepatitis C?
A hepatologist (liver specialist), a gastroenterologist or an infectious disease doctor, and, for people without cirrhosis, often a primary care doctor using a simplified treatment plan[9]. Many addiction treatment clinics now treat hepatitis C on site.
Is treatment in the hospital or at home?
At home. The treatment is oral pills[1], with blood tests before and after. A hospital stay is for complications of advanced liver disease, not for the antiviral course itself. Researchers are even testing how little monitoring is needed: the MINMON trial gave 394 people an 84-day course with very few clinic visits and tracked their quality of life[11]. It is a study of how treatment is organized, not of cannabis.
Are there home remedies for hepatitis C?
None that cure it or slow it down. Herbal supplements sold for “liver support” have not been shown to clear the virus, and some of them strain the liver themselves or interact with antivirals. What does help at home: no alcohol, a healthy weight, vaccines against hepatitis A and B[8], and asking before starting any new product, cannabis included.
Where are you with hepatitis C right now?
Choose the closest; the answer points to the part of this page that fits.
Choose the closest situation above.
Not tested yet: a single blood test is recommended for every adult[6]. Start with how testing works.
Antibody positive: this shows an infection at some point, not necessarily now; the RNA test decides[6]. See what a positive antibody test means.
Diagnosed, not treated: the first appointment is with a doctor who can start antivirals; cannabis is a later, separate question. Then read what to bring to a cannabis evaluation.
On treatment now: the priority is finishing every pill. Read whether cannabis affects treatment before you change anything.
Cured, still have symptoms: fatigue, pain or poor sleep can outlast the virus. This is where a symptom conversation with a physician fits, see what this means if you are considering it.
Is there a vaccine for hepatitis C? Prevention and testing
No. There is no vaccine for hepatitis C[1]. There are safe vaccines against hepatitis A and hepatitis B, and doctors recommend them for people with hepatitis C[8]: a second virus in an already inflamed liver is the last thing it needs. Having had hepatitis C, or being cured of it, does not protect you from catching it again.
| Question | Hepatitis B | Hepatitis C |
|---|---|---|
| How it spreads | Blood, semen and other body fluids, including during sex and birth[12] | Blood, most often through shared injection equipment[3] |
| Vaccine | Yes, recommended for all infants and most adults[12] | No[1] |
| Can it be cured | Chronic hepatitis B can be managed with medicines, which are not a cure[12] | Yes, in more than 95% of people with 8-12 weeks of pills[1] |
| How often it becomes chronic | Depends strongly on age at infection | More than half of infections[2] |
How testing works
- Antibody test. A blood test that shows whether you have ever been infected. The CDC recommends it for all adults at least once, and during every pregnancy[6]. A large study at two New York City hospitals tested 7,429 women giving birth and found hepatitis C in 0.75%, and only 41.1% of those had a known risk factor, which is why testing does not wait for one[13].
- RNA test. If antibodies are found, this test shows whether the virus is still in the blood today. Antibodies stay for life, even after cure; RNA is what tells active infection[6].
- Genotype, if your doctor orders it. The virus comes in several strains (genotypes), and their mix differs from region to region: a 2015 study from southern Turkey, for example, found genotype 3 common among carriers there[14]. Many current treatments work across genotypes, so not every patient needs this test.
Testing only helps if the next step happens. In rural Appalachia, among 254 people who use drugs and tested antibody positive, the chance of contacting a health care provider fell with every six months that passed (OR 0.6), and people with health insurance were about twice as likely to make contact (OR 2.1)[15]. Bringing testing to people works: a French community program reached 554 people who use drugs, and 75.5% of those eligible started treatment, with 73% of the treated cured at week 12[16]. If your test comes back positive, book the follow-up before the result fades into the background.
How to prevent it
- Never share needles, syringes, cookers or other injection equipment; syringe services programs provide sterile supplies[3].
- Keep razors, toothbrushes, nail clippers and glucose monitors to yourself[3].
- Choose licensed tattoo and piercing studios that use sterile equipment[3].
- Use condoms, especially with several partners or HIV[3].
- Use a cannabis device of your own rather than a shared pipe, joint or vape.
What does a positive antibody test mean?
That you were infected at some point. It does not tell whether the virus is still there: you may have cleared it, been cured, or still carry it. The RNA test answers that[6]. “Hepatitis C Ab” and “anti-HCV” on a lab report are the same antibody test.
Can the test be a false positive?
Yes, an antibody test is occasionally positive in someone who was never infected, particularly in groups where hepatitis C is rare. That is one more reason a positive antibody result is always followed by an RNA test before anyone talks about treatment[6].
What hepatitis C does to your liver and body
Left untreated, chronic hepatitis C damages the liver slowly, in stages that can take decades. Each stage is easier to stop than the next, and antiviral cure can halt the process at any of them.
Inflammation
The virus keeps the liver inflamed. Most people feel nothing; a blood test shows raised liver enzymes.
Fibrosis
Scar tissue builds up where liver cells were damaged. Doctors measure it with a scan or a blood score.
Cirrhosis
Scarring reshapes the liver. About 5 to 25 of every 100 people with chronic infection reach it over 10 to 20 years[2].
Liver failure or cancer
The end stages. Chronic hepatitis C is a leading cause of liver cancer in the United States[1].
The effects reach beyond the liver. People with chronic hepatitis C often describe fatigue, joint and muscle aches, trouble concentrating and low mood, and the infection is linked with changes in blood sugar and fats. Depression is common enough after diagnosis that it deserves its own conversation, see depression and medical cannabis. Chronic hepatitis C is also the leading cause of liver transplants in the United States[1].
Can hepatitis C cause cancer?
Yes. Chronic hepatitis C is a leading cause of liver cancer in the US[1], mostly in people who already have cirrhosis. After cure, people with cirrhosis still need regular liver cancer screening, because the scarred liver keeps some risk.
Is hepatitis C fatal?
It can be, through cirrhosis, liver failure and liver cancer, usually after many years. Treatment changes that: cure stops the damage from progressing, and most people treated before cirrhosis go on to a normal life expectancy.
Does the liver recover after cure?
Inflammation settles and early scarring can partly reverse. Not everything resets: some changes in how the body handles fats and sugar can outlast the virus, and people with cirrhosis keep needing follow-up. Cure is the start of looking after the liver, not the end.
Does cannabis help with hepatitis C?
Against the virus, there is no evidence in people. For symptoms, it is a question for a physician, because no study of cannabis for fatigue, nausea or sleep in hepatitis C exists yet. What research does offer is narrower and more interesting: a link with body weight, a clue about the body’s own cannabinoids, and a computer model. THC and CBD act differently, so a finding about one does not carry over to the other.
Choose a question
The virus
A 2024 computer study screened cannabis plant compounds against a viral replication enzyme (NS5B) and picked 31 candidates for further work[17].
Computer modeling only, not tested in cells, animals or people.
A starting point for drug designers. It says nothing about using cannabis against hepatitis C.
Symptoms
Nothing yet in hepatitis C: no trial has given cannabis for fatigue, nausea, appetite or sleep in people with this infection.
No direct evidence. Knowledge about these symptoms comes from other conditions, see nausea and insomnia.
A reasonable question for a physician, weighed against your liver and medicines, not an established treatment.
Weight and metabolism
A snapshot of 6,348 adults with chronic hepatitis C in France: 12.4% currently used cannabis, and they were obese less often than people who never had[18].
A link at one point in time; it cannot show that cannabis lowered weight.
Interesting for fatty liver research. See the numbers.
The body’s own cannabinoids
Blood from 30 people with chronic hepatitis C compared with 30 healthy blood donors: 11 members of the endocannabinoid family were raised[19].
A small case-control study of how the virus changes body chemistry.
The virus touches the system cannabis acts on. Whether that matters for treatment is unknown. Background: the endocannabinoid system.
Computer and laboratory results do not transfer to people: a compound that fits a viral enzyme on screen may never reach the liver, or may be harmful at the dose needed.
Does cannabis affect hepatitis C treatment?
The best data available say that cannabis use did not lower cure rates. That comes from a large German registry of people treated for hepatitis C while on opioid substitution therapy, a group where cannabis use is common.
Limits: an observational registry, not a trial; a specific group of patients on opioid substitution; cannabis use reported by patients, without dose or product. It shows that cannabis users can be cured, not that cannabis is harmless during treatment.
What makes the biggest difference is taking every pill. In a 2024 study of 493 people who inject drugs, those whose self-reported adherence ran at least 25 points above the electronically measured one were cured less often: 86.7% against 95.8%[21]. Anything that makes you forget doses, cannabis included, matters more than any direct interaction.
Drug interactions to discuss
Open each one. This is what the research here recorded, not a complete list.
Alcohol clinical data
In a randomized trial of a behavioral program for young adults with hepatitis C who injected drugs, those who used marijuana moved from not drinking back to drinking about three times as often (RR 3.11)[22]. Alcohol is the substance that harms an infected liver most, so this is the interaction to take seriously. More in cannabis, alcohol and the liver.
Antiviral regimens (sofosbuvir, velpatasvir and others) clinical data
The registry above found the same cure rate in cannabis users[20], but the studies here did not test specific drug pairs. Your hepatologist checks the regimen against everything you take, including CBD products.
Opioid substitution and sedatives mechanism only
Methadone, buprenorphine, benzodiazepines and sleeping pills each slow breathing and reaction time, and THC adds drowsiness of its own. The combination raises the risk of oversedation and falls. This rests on how the drugs work; the studies here did not measure it.
CBD and liver enzymes mechanism only
CBD and THC are broken down by the same liver enzymes (CYP450) that handle many medicines, and CBD can slow that system down. In a liver that is already inflamed, this deserves a look at your liver tests. No study here measured it in people with hepatitis C.
What to ask your doctor before starting
- Is my treatment finished, and when is my cure test (SVR) due?
- Could any product I am considering interact with my antivirals or substitution therapy?
- What do my liver tests and fibrosis stage say about adding anything new?
- THC, CBD or neither, and why, for the symptom I want help with?
- What should make me stop right away?
Is cannabis bad for the liver with hepatitis C? Why alcohol matters
Nobody can say for sure, because the long studies that would answer it have not been done. Researchers who studied cannabis in people with hepatitis C say so directly: following people over years is needed to learn what cannabis does to liver outcomes[18]. What is known is how the forms differ on the way in. Swallowed products (edibles, capsules, oils) pass through the liver before they reach the blood, so the liver meets the full dose first. Inhaled forms reach the blood through the lungs, but whatever is absorbed is still broken down by the liver later.
Can cannabis cause hepatitis? Cannabis is not a hepatitis virus and cannot give you hepatitis C. Liver inflammation from cannabis products is not something the studies here reported; the realistic liver risks for someone with hepatitis C are alcohol, untreated infection, extra weight and unchecked supplements.
Alcohol is the one to watch. It speeds up scarring in a liver infected with hepatitis C, and treatment guidance asks people to stop or cut down. In the same behavioral trial, young adults with hepatitis C who had already been diagnosed with liver disease were more likely to reach abstinence (RR 1.88)[22] – knowing about the liver helped. That makes the next finding worth knowing before you start anything.
Ways to use cannabis: what each form avoids and what remains
Cannabis is not only smoked. People also vape it, swallow it as gummies, capsules or oils, hold drops under the tongue, or put it on the skin. For someone with hepatitis C, each form avoids some concerns and keeps others, and none of them is automatically the safe one. This section explains the differences; it does not recommend a form.
How is it used, or how would it be?
Choose the closest; most people combine more than one.
Specific to smoking
Joints, blunts, pipes and bongs burn plant material, and the smoke irritates the throat and lungs. Blunts and many joints add tobacco, which carries its own liver cancer risk. The effect starts within minutes and is hard to measure in milligrams.
Specific to vaping and dabbing
Dry-herb vaporizers, oil pens and cartridges avoid burning, but hot vapor still travels the same airways. Concentrates used for dabbing (wax, shatter, rosin) are very strong, which makes the dose even harder to control.
Shared devices
A mouthpiece passed around can carry blood from cracked lips or bleeding gums. With a blood-borne virus, a pipe, joint or vape of your own protects the people you share with, and you from a second infection after cure.
Specific to edibles and capsules
Gummies, chocolates, drinks, capsules and swallowed oils avoid smoke and shared mouthpieces. They pass through the liver before reaching the blood, start slowly, often after an hour or more, and last for hours. The classic mistake is a second piece “because the first did nothing.”
Specific to tinctures and sprays
Drops held under the tongue and mouth sprays avoid the lungs and are measured by the drop or spray. Part of the dose is still swallowed and goes through the liver, and some oils are made with alcohol.
Specific to topicals and patches
Creams and balms act mainly where they are applied and are not a way to treat fatigue or nausea. Transdermal patches are different: they deliver cannabinoids into the bloodstream, so liver processing and interactions apply to them as to any other form.
Specific to prescription cannabinoids
Dronabinol (Marinol, Syndros), nabilone (Cesamet) and cannabidiol (Epidiolex) are FDA-approved medicines with an exact dose, prescribed by a doctor and filled at a pharmacy, not bought with a medical card. None is approved for hepatitis C.
True of every form
- Whatever reaches the blood is processed by the liver.
- It can interact with antivirals, opioid substitution therapy and sedatives.
- THC can cause drowsiness and slower reactions.
- No driving after use.
Choosing a form is a conversation for the appointment.
All forms as a table
| Form | What it avoids | What remains |
|---|---|---|
| Smoking | Delay in onset | Smoke in the airways, tobacco in blunts, shared devices, hard-to-measure dose, liver processing, interactions |
| Vaping and dabbing | Burning plant material | Hot vapor in the airways, very strong concentrates, shared devices, liver processing, interactions |
| Edibles and capsules | Smoke and vapor, shared mouthpieces | First pass through the liver, slow and long effect, risk of a repeat dose, interactions |
| Tinctures and sprays | Smoke and vapor, shared mouthpieces | Partly swallowed dose, alcohol in some oils, interactions, drowsiness |
| Topicals | Most effects beyond the skin | Skin reactions; no effect on fatigue or nausea |
| Transdermal patches | Smoke, vapor and swallowing | Liver processing, interactions, drowsiness |
| Prescription cannabinoids | Unknown product content | Drowsiness, dizziness, interactions; not approved for hepatitis C |
Cannabis, CBD and fatty liver: what is known
Fat in the liver and hepatitis C make each other worse, and extra weight is one of the things that speeds liver scarring. That is why one finding draws attention: in a large French cohort of people with chronic hepatitis C, current cannabis users were heavier less often[18]. It is a link, not proof. The study could not separate THC from CBD: use was self-reported, without dose or product, and it does not point to any dose or “best” product for fatty liver. Weight and metabolism have their own page: obesity and medical cannabis.
Were cannabis users heavier or lighter?
How to read it: each row compares current cannabis users with people who never used it, among 6,348 adults with chronic hepatitis C[18]. The dot is the estimate, the line is the likely range (95% CI), the gray line means no difference[18].
estimate · likely range (95% CI) · no difference
Show as a table
| Outcome | Estimate | 95% CI | Measure |
|---|---|---|---|
| Central obesity (waist size) | 0.45 | 0.37-0.55 | Adjusted odds ratio (aOR)[18] |
| Obesity by BMI | 0.27 | 0.19-0.39 | Adjusted relative risk ratio (aRRR)[18] |
| Overweight by BMI | 0.47 | 0.38-0.59 | Adjusted relative risk ratio (aRRR)[18] |
Two things this chart cannot tell you: whether cannabis would change the weight of someone who starts it, and whether it does anything to fat already in the liver. People with fatty liver are usually advised to focus on weight, diet, activity and alcohol; any cannabis question sits on top of that, not instead of it.
What the research shows, from strongest to weakest
Not all studies count the same. A randomized trial in people answers “does it work?” far better than a computer model or a snapshot survey. Here is what exists for cannabis and hepatitis C at each level, with the background studies clearly marked.
| Level | What exists for hepatitis C | What it can and cannot tell you |
|---|---|---|
| Trials in people | No trial has given cannabis to people with hepatitis C. The trials here tested a behavioral program, in which marijuana users returned to drinking more often[22], and ways of delivering antiviral treatment[11][16]. | Strong on alcohol and on how to organize treatment; silent on whether cannabis helps symptoms. |
| Observational studies | Registries and cohorts: cannabis use did not lower cure rates on antivirals[20]; cannabis users were obese less often[18]; the virus raises the body’s own cannabinoids[19]. | Shows links, not cause; cannabis use is self-reported, without dose or product. |
| Computer and lab work | A computer screen of cannabis plant compounds against a viral enzyme[17]. | Explains why scientists are curious; says nothing yet about patients. |
Browse the studies yourself
Every study cited on this page, in plain words. Neutral and negative results are included.
Marijuana use and a return to drinking
In a behavioral program for young adults with hepatitis C, marijuana users moved from abstinence back to alcohol about three times as often (RR 3.11); a known liver diagnosis made abstinence more likely (RR 1.88)[22].
Antiviral treatment with minimal monitoring
An 84-day course with very few clinic visits; the trial tracked quality of life, which rose most in people with cirrhosis[11].
Bringing testing and treatment to people who use drugs
A community program found 32.6% with hepatitis C antibodies; 75.5% of those eligible started treatment, and 73% of the treated were cured at week 12[16].
Cannabis and alcohol did not lower cure rates
In the German Hepatitis C Registry, 96% of patients who completed antivirals were cured; 19.2% used cannabis, and neither cannabis nor alcohol made cure less likely[20].
Cannabis users were obese less often
Current users had lower odds of central obesity (aOR 0.45), obesity by BMI (0.27) and overweight (0.47) than never users; a snapshot, not proof of cause[18].
The virus raises the body’s own cannabinoids
Plasma of people with chronic hepatitis C showed 21 raised and 34 lowered fat-related molecules, including 11 raised members of the endocannabinoid family[19].
Antiviral cure on opioid agonist treatment
97.5% were cured among those who completed treatment, 84.5% counting everyone who started; the study had no control group[10].
Overstated adherence and lower cure
People who overstated pill-taking by 25 points or more were cured less often (86.7% against 95.8%), a negative finding about adherence, not cannabis[21].
Hepatitis C at delivery in New York City
0.75% of women giving birth had hepatitis C antibodies, and fewer than half had a known risk factor[13].
What happens after a positive screen
Contact with a provider grew less likely as months passed (OR 0.6 per six months) and more likely with insurance (OR 2.1)[15].
Hepatitis C among people who inject drugs
In a Saudi Arabian hospital, 42.7% of people who injected drugs had hepatitis C[4].
Hepatitis C among Hispanics in California
Heroin use (OR 6.84) and prior methadone treatment (OR 7.28) were tied to infection; a mixed picture across groups[5].
Which strain of the virus is common where
Genotype 3 was common among hepatitis C carriers in a province of southern Turkey, a neutral finding on how strains vary by region[14].
Cannabis compounds screened against a viral enzyme
A deep-learning screen picked 31 plant compounds that fit the NS5B enzyme on screen; none was tested in cells, animals or people[17].
No studies of this type are cited on this page.
What kinds of studies is this evidence built on?
How to read it: each row is one kind of study, and the bar shows how many published studies on hepatitis C and cannabis are of that kind. Stronger designs are at the top. Gray bars are commentary and lab work, which cannot answer whether something helps patients.
Show as a table
| Design | Studies |
|---|---|
| Meta-analyses | 3 |
| Randomized trials | 2 |
| Other clinical trials | 4 |
| Cohort studies | 18 |
| Case-control studies | 1 |
| Cross-sectional studies | 10 |
| Surveys | 2 |
| Case reports | 1 |
| Narrative reviews | 5 |
| Lab and computer studies | 4 |
| Who was studied | Studies |
|---|---|
| People in clinical studies | 12 |
| People observed, not treated | 20 |
| Whole populations | 24 |
| Cells and molecules | 2 |
| Not classified | 12 |
What science doesn’t know yet
For cannabis and hepatitis C, the gaps are most of the story. The researchers behind these studies name them themselves.
- No long studies of liver outcomes. Whether cannabis speeds up, slows or does nothing to scarring over years has not been followed; the authors of the largest study ask for exactly that[18].
- Most work is observational, some without a comparison group. The real-world antiviral cohort on opioid agonist treatment had no control group and missing data on liver disease stage[10].
- Cannabis use is self-reported, without dose or content. Nobody recorded how often, how much, or whether products were THC or CBD[18].
- No dosing data for cirrhosis. No study here looked at how a scarred liver handles cannabinoids, or what amount would be reasonable.
- The antiviral idea exists only on a computer. The compounds that fit the viral enzyme have not been tested in cells, animals or people[17].
- Special populations. The reassuring cure-rate data come from people on opioid substitution therapy[20], and may not describe everyone with hepatitis C.
Until those studies exist, the decision rests on your own liver tests, medicines and history, which is exactly what a physician reviews at the appointment.
Who should not use cannabis for this
For some people with hepatitis C the answer is “not now” or “not at all,” whatever the symptom. Studies in this field leave these groups out, so there is no evidence of safety for them.
- Signs of a failing liver that no doctor has checked – yellow skin or eyes, a swelling belly, confusion, vomiting blood or black stools.
- Recovery from alcohol use disorder – marijuana use was linked to a return to drinking in young adults with hepatitis C[22].
- Pregnancy or breastfeeding – THC passes to the baby, and pregnancy was an exclusion in hepatitis C treatment trials.
- A history of psychosis – THC can bring it back. See cannabis and psychosis.
- Several sedating medicines already – opioids, benzodiazepines, sleeping pills, or high-dose opioid substitution.
- Waiting for a liver transplant – transplant programs set their own rules on cannabis, and they decide.
Talk to a licensed physician about whether any of these apply
Is hepatitis C a qualifying condition for a medical card?
It depends on your state. Every medical cannabis program keeps its own list of qualifying conditions, and a physician has to match your diagnosis to that list, not to a symptom. Some programs name hepatitis C outright. Others do not mention it but cover conditions that often come with it – chronic pain, severe nausea, HIV – and some let a physician certify any condition they judge debilitating.
The lists change as legislatures and health departments update them, so the current wording for your state is the one that counts. The physician confirms it at the evaluation, using your records: the diagnosis code B18.2 on a chronic hepatitis C chart, for instance[7].
Hepatitis C is named in your state
The simplest case. Bring a record of the diagnosis (a lab result with a positive RNA test or a note from the doctor who treats it), and the physician evaluates you against that listed condition.
A condition you also have is listed
Chronic pain, nausea, HIV, depression or insomnia may be on the list even where hepatitis C is not. What counts is a diagnosis in your records, not a symptom alone.
Neither is on the list
A card may not be available yet where you live. Some states let physicians certify other debilitating conditions or accept petitions to add new ones.
What else has a doctor diagnosed?
State lists name diagnoses, not symptoms: pick what is in your records.
Chronic pain: the most widely listed condition across state programs, and joint and muscle aches are common with hepatitis C. Read chronic pain and medical cannabis.
Nausea: severe or persistent nausea is listed in many programs. Read nausea and medical cannabis.
HIV: HIV and hepatitis C share routes of spread, and HIV is on most state lists. Read HIV and medical cannabis.
Depression: fewer states list it, and THC can affect mood in both directions. Read depression and medical cannabis.
Insomnia: a diagnosed sleep disorder is listed in some programs. Read insomnia and medical cannabis.
None of these: then the decision rests on your state’s wording and the physician’s judgment. Start with your state’s medical marijuana laws.
Medical card or recreational purchase
In states with adult-use sales, adults can buy without a card. A card still changes several things, though the details are set state by state.
| Aspect | With a medical card | Recreational |
|---|---|---|
| Taxes | Often lower; some states waive part of the cannabis tax for patients | Full state and local cannabis taxes |
| Purchase and possession limits | Often higher; depends on your state | Set for adult-use buyers |
| Products | Access to medical dispensaries and, in some states, medical-only products | Adult-use product range |
| Age | Patient age rules set by each program | Adult-use age limit set by the state |
| Physician involvement | A licensed physician reviews your liver, conditions and medicines | None |
| Document | State card or recommendation, recorded in a confidential registry | Government ID only |
Will a card save you money?
It can, but only where your state taxes patients less than recreational buyers, and the amount depends on your state’s tax rates and how much you buy. Weigh that against the evaluation fee and any state registration fee. The breakdown is in medical vs. recreational cannabis taxes, and the wider differences in medical and recreational cannabis compared.
What the program in your state involves
Qualifying is the first of two steps. In most states a physician’s recommendation is followed by registration with the state health department, which issues the card and enters you in a confidential patient registry; in a few, the recommendation itself is what a dispensary asks for. Purchases happen at licensed dispensaries, some of which deliver, and products there are lab-tested and labeled with their THC and CBD content, useful when your physician wants to know exactly what you take.
Many state laws also let a patient name a registered caregiver who may buy and handle products on their behalf; who qualifies is set by each state. Cards from one state are not automatically valid in another; see which states accept out-of-state cards. If a card goes missing, here is what to do if your card is lost. Possession limits, home growing and taxes are listed state by state on the laws and regulations pages.
Privacy, firearms, work and driving
Who finds out about my diagnosis and card?
Your medical records, including a hepatitis C diagnosis, are protected under the HIPAA Privacy Rule[23], and state patient registries are confidential; dispensaries and law enforcement can usually check only whether a card is valid.
Can I own a firearm with a medical card?
Federal law bars anyone who is an “unlawful user” of a controlled substance from having a firearm[24], and cannabis remains federally controlled, so a state card does not change the federal rule. Gun purchase forms ask about this directly.
Does my employer have to accept it?
Employment protections for card holders differ by state, and many employers can still enforce drug-free policies, especially in safety-sensitive and federally regulated jobs. Read your state’s rules on the laws and regulations pages.
Can I drive?
Not after use. Driving under the influence of cannabis is illegal in every state, card or not, and THC slows reactions whatever the form, edibles included, whose effect can arrive hours later. Combined with opioid substitution or sleeping pills, the effect is stronger.
What this means if you are considering it
A good evaluation is a conversation about one or two specific symptoms, the state of your liver, the medicines you take and what would count as “better.” It goes faster and safer when the facts are on the table, and with hepatitis C, the liver facts matter most.
What to bring to the appointment
Tap each item as you get it ready.
Questions worth asking
- Does my liver stage change what is reasonable to try?
- Which of my medicines could interact, and what would we watch for?
- THC, CBD or both, and why that choice for this symptom?
- How would we know within a few weeks whether it is helping?
- Should my hepatologist know, and what should I tell them?
An evaluation makes sense if
- A specific symptom, nausea, sleep, appetite, pain, has not settled with the usual steps.
- The virus is treated, or treatment is planned with a doctor.
- Your full medicine list and liver tests can be reviewed.
- Your state’s program covers your diagnosis or a related one.
It is not the right step if
- The hope is to clear the virus with cannabis.
- New liver symptoms have not been checked by a doctor.
- There has been a recent relapse into drinking.
- You are pregnant or breastfeeding.
This page summarizes published research for education. It does not replace a physician’s advice. Cannabis does not treat or cure hepatitis C; antiviral medicines do. Do not stop or delay antiviral treatment to try cannabis.
How to get a medical card for hepatitis C online
Everything happens online, so there is no waiting room and nowhere to travel. Four steps take you from the first form to a card in your hand.
Fill in the intake form
Your state, your diagnoses and your current medicines. Have the record of the hepatitis C diagnosis and your latest liver tests ready to upload.
See a physician licensed in your state
A one-on-one appointment online. You agree on the time with the physician; keep an hour free rather than a minute.
Receive your signed recommendation
If the physician approves, the signed recommendation can arrive in your account in as little as 15 minutes after the appointment, depending on your state.
Register with your state
Where required, you submit the recommendation to the state program, which reviews it and issues the card.
What you end up with
Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.
- 150,000+patients evaluated – everyone who has been through an appointment with us, in every state where we are licensed
- Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side
A recommendation from a physician licensed where you live, and, once your state registers it, a card that lets you buy at licensed dispensaries. After payment, your documents stay in your account and documents, and how the medical card works explains the evaluation in detail. The physicians who see patients are listed on our physicians page.
The evaluation fee for your state is shown before you pay; a state fee, where one exists, is paid to the state. Programs for veterans and for people with low income are available in some states. When the card nears its end date, renewal is a repeat evaluation with your updated liver tests and medicines. Choose your state from the list at the top of this page.
Questions people ask about hepatitis C and cannabis
Can hepatitis C be cured?
Does hepatitis C go away on its own?
Sometimes, in the first months after infection. More than half of people do not clear it and develop chronic infection[2], which rarely goes away without treatment.
Is hepatitis C acute or chronic?
Both are possible. Acute means the first months after infection; chronic means the virus is still in the blood after that. Most people who are diagnosed have the chronic form, often found years after infection by a routine test.
Can hepatitis C cause cancer?
Yes. Chronic hepatitis C is a leading cause of liver cancer in the United States[1], mostly after cirrhosis develops. Curing the virus lowers the risk, and people with cirrhosis keep having regular screening after cure.
Can I use medical cannabis while on hepatitis C treatment?
That decision belongs with your hepatologist and the physician who evaluates you. In a large German registry, cannabis use did not lower cure rates on antivirals[20], but the studies did not test specific drug pairs, and missing doses lowers cure[21]. Tell your treating doctor about any product you use.
Is CBD safe for the liver?
Not automatically. CBD does not cause a high, but it is processed by the liver and can slow the enzymes that clear other medicines. No study here measured CBD’s effect on the liver in hepatitis C. Show the physician the product label and your liver tests.
Can cannabis cause hepatitis?
Is hepatitis C a qualifying condition in my state?
Some states name it, others cover conditions that often come with it, such as chronic pain, nausea or HIV, and some let physicians certify other debilitating conditions. See the three cases above and check your state’s medical marijuana laws.
What happens after the doctor recommends cannabis?
The signed recommendation can arrive in your account in as little as 15 minutes after the appointment, depending on your state. Where your state requires it, you register with the state program, which issues the card; then you can buy at licensed dispensaries. Keep your hepatologist informed. Details are on how the medical card works.
What about delta-8 THC or CBD products sold without a card?
Hemp-derived products sold in shops and online are often less tightly regulated than dispensary products, and labels may not match what is inside. Delta-8 THC acts much like regular THC, with the same drowsiness and interaction questions. With a liver to protect, knowing exactly what you take matters.
Can I use my card in another state?
Sometimes. Reciprocity (one state honoring another state’s card) exists in some states and not others. Check which states accept out-of-state cards and traveling with cannabis before a trip.
What if my card is lost?
Most states let you request a replacement from the program that issued it. The steps are in what to do if your card is lost and the medical card FAQ.
How do I renew my medical card?
Cards expire on a schedule your state sets, and renewal means a repeat evaluation with updated medicines and a new recommendation. Bring any change since last time: a completed antiviral course, new liver results, new prescriptions. Choose your state from the list at the top of this page, or see how the medical card works.
Is an online evaluation legitimate?
Yes, where state law allows telemedicine for medical cannabis evaluations. The appointment is with a physician licensed in your state, one-on-one, and the recommendation is the same document an in-person visit would produce. Your records stay protected under HIPAA[23].
More research on cannabis and hepatitis C
This page cites a selection of studies. Our research library holds every study we track on cannabis and hepatitis C, from laboratory work to clinical trials, and lets you filter them by cannabinoid, study type and year.
- studies
- 180+
- in people
- 73
- clinical trials
- 9
Related conditions
Hepatitis C often travels with other diagnoses, and some of them are on more state lists. Each page below covers its own research and qualifying rules.
Background and latest articles
For background on how cannabis works in the body, and for new articles as research comes out:
References
24 sources
- 1. Centers for Disease Control and Prevention. Hepatitis C Basics. 2025.
- 2. Centers for Disease Control and Prevention. Clinical Overview of Hepatitis C. 2025.
- 3. Centers for Disease Control and Prevention. Preventing Hepatitis C. 2025.
- 4. Prevalence of hepatitis C viral infection among injecting drug users in a Saudi Arabian hospital: A point cross sectional survey. DOI: 10.4081/jphia.2018.726 PMID: 30079162
- 5. Hepatitis C Infection Among Hispanics in California. DOI: 10.1080/10550887.2015.1074500 PMID: 26372008
- 6. Centers for Disease Control and Prevention. Testing for Hepatitis C. 2025.
- 7. Centers for Medicare & Medicaid Services. ICD-10-CM Codes. 2026.
- 8. Centers for Disease Control and Prevention. Clinical Care of Hepatitis C. 2025.
- 9. American Association for the Study of Liver Diseases and Infectious Diseases Society of America. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. 2023.
- 10. Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study. DOI: 10.1093/ofid/ofaa317 PMID: 32875003
- 11. Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life. DOI: 10.1007/s11136-025-03922-1 PMID: 40019678
- 12. Centers for Disease Control and Prevention. Hepatitis B Basics. 2025.
- 13. Hepatitis C Seroprevalence Among Consecutive Labor and Delivery Admissions in Two New York City Hospitals. DOI: 10.1093/ofid/ofaa514 PMID: 33241070
- 14. Distribution and predominance of genotype 3 in hepatitis C virus carriers in the province of kahramanmaras, Turkey. DOI: 10.5812/hepatmon.15(4)2015.25142 PMID: 25972903
- 15. Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs. DOI: 10.1016/j.drugpo.2017.05.045 PMID: 28648353
- 16. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C. DOI: 10.1093/ofid/ofac181 PMID: 35774932
- 17. Geometric Deep learning Prioritization and Validation of Cannabis Phytochemicals as Anti-HCV Non-nucleoside Direct-acting Inhibitors. DOI: 10.1177/11795972241306881 PMID: 39678171
- 18. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort. DOI: 10.1186/s42238-022-00138-9 PMID: 35690798
- 19. Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols. DOI: 10.3390/ijms24021407 PMID: 36674922
- 20. Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R). DOI: 10.1177/1178221819835847 PMID: 30944519
- 21. Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study. DOI: 10.1186/s12879-024-09124-3 PMID: 38395747
- 22. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. DOI: 10.1016/j.jhep.2010.10.028 PMID: 21145862
- 23. U.S. Department of Health and Human Services. The HIPAA Privacy Rule. 2024.
- 24. Legal Information Institute, Cornell Law School. 18 U.S. Code § 922: Unlawful acts. 2024.